Menu

Nobel Laureate Roger Tsien Dies

One of the pioneers in developing fluorescent proteins for biological studies was 64 years old.

Aug 31, 2016
Kerry Grens

UNIVERSITY OF CALIFORNIA, SAN DIEGORoger Tsien, a biochemist at the University of California, San Diego, (UCSD) who earned a Nobel Prize for Chemistry in 2008 for his work on green fluorescent protein, died last week (August 24) in Oregon. He was 64.

“Roger’s vision was vast and yet incredibly precise,” David Brenner, the vice chancellor at the UCSD Health Sciences and dean of UCSD School of Medicine, said in a statement sent to The Scientist. “He saw both the big picture, but also the incredible need to see and understand—in glorious color—all of the infinitesimal details that make it up, that make up life.”

Tsien is best known for his work on green fluorescent protein (GFP)—but he expanded fluorescent labeling into different colors, and even the infrared. “By working to understand the mechanisms behind GFP's florescence, Tsien has developed several related proteins that glow in virtually all the colors of the rainbow,” The Scientist reported in 2008 when Tsien won the Nobel with Osamu Shimomura and Martin Chalfie. Tsien and his colleagues later designed a technique to visualize fluorescent proteins using electron microscopy.

“I’ve always been attracted to colors,” Tsien told the San Diego Union-Tribune in 2008. “Color helps make the work more interesting and endurable. It helps when things aren’t going well. If I had been born color-blind, I probably never would have gone into this.”

According to the Union-Tribune today (August 31), Tsien died on a bike trial in Eugene, Oregon, but the precise cause of his death was not yet determined.

“He was ever the adventurer, the pathfinder, the free and soaring spirit,” Tsien’s wife Wendy said in the statement from UCSD. “Courage, determination, creativity and resourcefulness were hallmarks of his character. He accomplished much. He will not be forgotten.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!